what to do in patients with early-stage tnbc who have not achieved a pcr?
Published 1 year ago • 2.5K plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
5:21
optimal neoadjuvant and adjuvant therapy for patients with early tnbc
-
2:21
the challenges of treating early-stage tnbc
-
5:53
treating early-stage tnbc
-
6:54
no pcr in patients after neoadjuvant chemotherapy in tnbc
-
1:22
immunological signatures to predict outcomes in patients with tnbc
-
1:02
pcr and survival after neoadjuvant chemotherapy in stage i tnbc: a registry-based study
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
5:38
transcode therapeutics begins dosing patients in phase 1 trial for metastatic cancer therapy
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
8:55
survival outcomes from the calgb 40603 study in triple-negative breast cancer
-
1:29
takeaways on the management of early-stage tnbc
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
28:25
metastatic triple-negative breast cancer ongoing trials
-
3:37
tnbc: immunotherapy in the neoadjuvant setting
-
3:28
immunotherapy in early-stage tnbc - where do we stand?
-
57:18
breast cancer
-
4:38
alice: atezolizumab immunogenic chemotherapy in metastatic tnbc
-
13:40
what is best approach for tnbc patient after achieving pcr
-
1:51
optimal chemotherapy combinations in tnbc gbrca subtypes